(Q38089931)

28 August 2017

Review on natriuretic peptides: where we are, where we are going (English)

1 reference

28 August 2017

Kevin Jiang

1

1 reference

28 August 2017

Kevin Shah

series ordinal

2

1 reference

28 August 2017

Lori Daniels

series ordinal

3

1 reference

28 August 2017

Alan S Maisel

series ordinal

4

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

Expert Opinion on Medical Diagnostics

28 August 2017

1 reference

28 August 2017

2

1 reference

28 August 2017

10

1 reference

28 August 2017

1137-1153

1 reference

Clinical manifestations, diagnostic assessment, and etiology of heart failure in elderly patients

28 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Effects of prehospital medications on mortality and length of stay in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Localization of the mosaic transmembrane serine protease corin to heart myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Molecular forms of human brain natriuretic peptide in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Characterization of molecular forms of probrain natriuretic peptide in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Human N-terminal proBNP is a monomer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Cardiac hormones as diagnostic tools in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Performance characteristics of four automated natriuretic peptide assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Plasma brain natriuretic peptide in assessment of acute dyspnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

The Natural History of Congestive Heart Failure: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

The epidemiology of heart failure: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Beta-blockers: the new standard of therapy for mild heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Usefulness of B-type natriuretic peptide (BNP) as a screen for left ventricular abnormalities in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Ten-year risk of false positive screening mammograms and clinical breast examinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Short-term serial sampling of natriuretic peptides in patients presenting with chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Prognostic value of plasma brain natriuretic peptide combined with left ventricular dimensions in predicting sudden death of patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Natriuretic peptides in heart valve disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

B-type natriuretic peptide and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

The natriuretic peptides in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Essential biochemistry and physiology of (NT-pro)BNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Deconvolution analysis of cardiac natriuretic peptides during acute volume overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Amino-terminal pro-brain natriuretic peptide to diagnose congestive heart failure in patients with impaired kidney function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Impact of age and sex on plasma natriuretic peptide levels in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Obesity and suppressed B-type natriuretic peptide levels in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Impact of obesity on plasma natriuretic peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Expression of natriuretic peptide receptors in human adipose and other tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

B-type natriuretic peptide levels in obese patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Increased plasma concentrations of brain natriuretic peptide in patients with acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

B-type natriuretic peptide-guided therapy and prognosis in acutely ill patients with pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Prognostic Role of Brain Natriuretic Peptide in Acute Pulmonary Embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Plasma brain natriuretic peptide concentration: impact of age and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Attenuation of biologic compensatory action of cardiac natriuretic peptide system with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Elevated brain natriuretic peptide in septic patients without heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Stimulation of brain natriuretic peptide release from the heart by thyroid hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Case report: recurrent heart failure with preserved ejection fraction but markedly elevated BNP in a 51-year-old female on hemodialysis with oversized AV fistula.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Brain natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

B-type natriuretic peptide and the stressed heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

The diagnosis of acute congestive heart failure: role of BNP measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.10.1137

10.1517/17530059.2.10.1137

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference